SciSparc Ltd. (SPRC) has released an update.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
SciSparc Ltd., a pharmaceutical company specializing in central nervous system disorders, has announced significant progress in its merger with AutoMax Motors, receiving court approval for shareholder meetings to approve the deal. The merger deadline has been extended to November 30, 2024, allowing additional time for the consummation of the agreement. This move could be a strategic effort to enhance SciSparc’s portfolio of cannabinoid-based pharmaceuticals.
For further insights into SPRC stock, check out TipRanks’ Stock Analysis page.